News & Insights

Drug Development is a complex and lengthy process that requires extensive testing and characterization of the molecule to ensure safety, efficacy, and potency of the molecule. One crucial aspect of this process is analytical method development and validation. Analytical method development is the process…

Watch our fourth combination products’ webinar, “Human Factors in Combination Products” presented by Anchal Choudhuri

Adeno-associated virus (AAV) vectors have been widely leveraged in gene therapy, and currently a number of products, including Luxterna® and Zolgensma®, have already been approved for gene replacement therapy using AAV vector technology.  To date, AAV vectors have been the workhorse of gene therapy…

Watch our second combination products' webinar, “Considerations for Delivery Device Companies” presented by Anchal Choudhuri and Christina Vessely.

Watch our first combination products' webinar, “Integration of Drugs and Delivery Devices” presented by Anchal Choudhuri and Christina Vessely.

Watch our on-demand webinar, “How to Elevate Your Nonclinical Safety Data Review and Decision Making” presented by Bruce Pearce, David Pepperl, Chris Scull and Laurie Iciek.

When you have an anomalous lab result, you just might be in trouble. However, Chris Vessely can help you close the case of what went wrong, help you find a way to save the day, and help keep you from getting in trouble in the first place.

Watch our on-demand webinar, "New FDA CAR-T Guidance: What Sponsors Need To Know"

Biologics Consulting is thrilled to announce